Lung Disease Summit: Recording
2024 Advanced Respiratory Disease and Lung Transplant Summit
Weill Cornell Medical Center | Uris Auditorium | 1300 York Ave., New York NY 10065
Program Overview
This Summit was recorded on September 26, 2024.
The 2024 Advanced Respiratory Disease and Lung Transplant Summit was recorded on Thursday, September 26, 2024.
The summit aims to provide a comprehensive platform for healthcare professionals, researchers, and specialists to discuss recent developments in the field of advanced lung diseases, including state-of-the-art therapies for chronic obstructive pulmonary disease (COPD), the latest diagnostic and treatment approaches to interstitial lung disease (ILD), novel treatments for cystic fibrosis (CF) and non-CF bronchiectasis, and multi-modality management of pulmonary hypertension (PH). We will highlight the importance of multi-disciplinary care of these complex patients with multi-morbidities, including surgical and non-surgical techniques for evaluation and management of gastrointestinal reflux, advanced therapies for lung disease (ECMO, LVRS, BLVR, atrial septostomy, Potts shunt) and the key therapeutic role of lung transplantation. By highlighting the latest research and technological advancements, the program seeks to enhance understanding and collaboration within the medical community.
Learning Objectives:
- Identify appropriate indications for referral and evaluation for advanced therapies such as ECOM, LVRS, BLVR and lung transplantation among patients with advanced lung diseases.
- Understand evidence-based diagnostic approaches and interventions for the management of patients with advanced lung diseases, including ILD, COPD, CF and non-CF bronchiectasis, PH, and GER-related aspiration.
- Discuss the pharmacologic, surgical and other treatment options for patients with advanced lung diseases.
Target Audience
This program has been designed for primary care physicians, pulmonologists, radiologists, thoracic surgeons, respiratory therapists, nurses, physician assistants, nurse practitioners, healthcare researchers, scientists, and other medical professionals involved in the care of patients with advanced lung disease.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Columbia University Department of Surgery and Amedco LLC. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians
Amedco LLC designates this live activity for a maximum of 7.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians Assistants
PAs may claim a maximum of 7.50 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
Nurse Practitioners
The American Academy of Nurse Practitioners Certification Board (AANPCB) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors and allow reciprocity for AANPCP continuing education credit. Maximum 7.50 hours.
American Board of Internal Medicine (ABIM) MOC
Successful completion of this CME
activity, which includes participation in the evaluation component, enables the
participant to earn up to 7.50 Medical Knowledge MOC points in the American
Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program.
It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting
ABIM MOC credit.
Satisfactory Completion
Learners must complete an evaluation form to receive a certificate of completion. Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed above, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
Refund Policy
Registration is limited and will be handled on a first-come, first-served basis. Telephone registrations/cancellations/refunds cannot be accepted.
Method of Participation
You will receive a confirmation email before the event with instructions for joining via Zoom and attending the Summit In-person instructions.
Weill Cornell Valet Parking: 525 East 68th Street (between York Avenue and East River) New York, NY 10065.
Tickets
In-person Registration Options
MD, DO, PhD
175.00 USD
RN, NP, PA
150.00 USD
Fellows, Residents, Students, VIP: FREE
0.00 USD
Virtual Registration Options
MD, DO, PhD
150.00 USD
RN, NP, PA
100.00 USD
Fellows, Residents & Students: FREE
0.00 USD
Exhibitors
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals will be participating on-site with an exhibit.
Janssen Pulmonary Hypertension | Johnson & Johnson Innovative Medicine
Johnson & Johnson Innovative Medicine, will be participating on-site with an exhibit.
PromptCare Specialty Pharmacy will be participating on-site with an exhibit.
No records found.
Agenda
Thursday, September 26
7:00 AM - 8:00 AM
7:00 AM - 8:00 AM
Registration | Breakfast | Exhibit Hall
8:00 AM - 8:15 AM
8:00 AM - 8:15 AM
Welcoming Remarks
Anna J. Podolanczuk, MD, MS
NewYork-Presbyterian/Weill Cornell Medical Center
8:15 AM
8:15 AM
Session One
8:15 AM - 8:45 AM
8:15 AM - 8:45 AM
State of the Art Therapy for Advanced COPD | Emphysema
William Zhang, MD
NewYork-Presbyterian/Weill Cornell Medical Center
8:45 AM - 9:15 AM
8:45 AM - 9:15 AM
Innovative Approaches in the Diagnosis & Treatment of ILD
Claire McGroder, MD
NewYork-Presbyterian/Columbia University Irving Medical Center
9:15 AM - 10:00 AM
9:15 AM - 10:00 AM
Case Discussion: Multidisciplinary Discussion (MDD) to Ensure Optimal ILD Diagnosis and Management
Moderator: Anna J. Podolanczuk, MD, MS, Weill Cornell Medicine
Case Presenters:
Case 1- Kristin Berger, MD, NewYork-Presbyterian/Weill Cornell Medical Center
Case 2- David Zhang, MD, NewYork-Presbyterian/Columbia
Panel Members:
Robert J. Kaner, MD, NYP/Weill Cornell
Christine K. Garcia, MD, PhD, NYP/Columbia
Anjali Saqi, MD, MBA, NYP/Columbia
Joanna Escalon, MD, NYP/Weill Cornell
Jessica K. Gordon, MD, Hospital for Special Surgery
10:00 AM - 10:15 AM
10:00 AM - 10:15 AM
Morning Break | Exhibit Hall
10:15 AM
10:15 AM
Session Two
10:15 AM - 10:45 AM
10:15 AM - 10:45 AM
Bronchoscopic & Surgical Lung Volume Reduction in Emphysema
Faisal Shaikh, MD, NewYork-Presbyterian/Columbia University Irving Medical Center
B. Payne Stanifer, MD, MPH, NewYork-Presbyterian/Columbia University Irving Medical Center
10:45 AM - 11:15 AM
10:45 AM - 11:15 AM
Diagnostic & Therapeutic Advances in Pulmonary Hypertension
Evelyn M. Horn, MD
NewYork-Presbyterian/Weill Cornell Medical Center
11:15 AM - 11:45 AM
11:15 AM - 11:45 AM
New Developments in Bronchiectasis and NTM
Meredith Turetz, MD
NewYork-Presbyterian/Columbia University Irving Medical Center
11:45 AM - 12:30 PM
11:45 AM - 12:30 PM
Lunch | Exhibit Hall
12:30 PM
12:30 PM
Session Three
12:30 PM - 1:00 PM
12:30 PM - 1:00 PM
Impact, Diagnosis & Management of Gastroesophageal Reflux (GER) in Advanced Lung Disease
Sydney F. Pomenti, MD, NewYork-Presbyterian/Columbia University Irving Medical Center
Frank D’Ovidio, MD, PhD, NewYork-Presbyterian/Columbia University Irving Medical Center
1:00 PM - 1:30 PM
1:00 PM - 1:30 PM
The Approach to Extracorporeal Membrane Oxygenation (ECMO) in the Management of Patients Suffering from Advanced Lung Disease
Cara Agerstrand, MD, NewYork-Presbyterian/Columbia University Irving Medical Center
Philippe Lemaitre, MD, NewYork-Presbyterian/Columbia University Irving Medical Center
1:30 PM - 2:15 PM
1:30 PM - 2:15 PM
Case Discussion: Diagnostic Dilemmas & Treatment Decisions in ILD, PH & COPD
Case Presenters
Case 1 Presenter: Christina Eckhardt, MD
NYP/Columbia
Case 2 Presenter: Erika S. Berman Rosenzweig, MD, NYP/Columbia
Case 3 Presenter: Ben-Gary Harvey, MD
NYP/Weill Cornell
2:15 PM - 2:30 PM
2:15 PM - 2:30 PM
Afternoon Break | Exhibit Hall
2:30 PM
2:30 PM
Session Four
2:30 PM - 3:00 PM
2:30 PM - 3:00 PM
Symptom Management & Palliative Care in Advanced Lung Disease
Bradley Hayward, MD
NewYork-Presbyterian/Weill Cornell Medical Center
3:00 PM - 3:30 PM
3:00 PM - 3:30 PM
When All Else Fails: The Role of Lung Transplantation, Indications & Patient Selection
William M. Whalen, MD, MS
NewYork-Presbyterian/Weill Cornell Medical Center
3:30 PM - 4:00 PM
3:30 PM - 4:00 PM
Post-Transplant Complications and the Role of Referring Physicians in Patient Care
Kemarut C. Laothamatas, MD
NewYork-Presbyterian/Columbia University Irving Medical Center
4:00 PM - 5:00 PM
4:00 PM - 5:00 PM
Case Discussion: Multidisciplinary Transplant Team Meeting
Moderator: Selim Arcasoy, MD, MPH, Columbia University Irving Medical Center
Case Presenter:
Mark Sonnick, MD, NYP/Columbia
Panel Members:
Lori Shah, MD, NYP/ Columbia
Hilary Robbins, MD, NYP/ Columbia
Luke Benvenuto, MD, NYP/ Columbia
Frank D’Ovidio, MD, PhD, NYP/ Columbia
Joshua R. Sonett, MD, NYP/ Columbia
Melinda Green, LCSW
David Federonko, MD, NYP/ Columbia
4:45 PM - 5:00 PM
4:45 PM - 5:00 PM
Closing Remarks | Submissions of Evaluations
Selim M. Arcasoy, MD, MPH
NewYork-Presbyterian/Columbia University Irving Medical Center
